A molecular rheostat: Co-operative rev binding to stem I of the rev-response element modulates human immunodeficiency virus type-1 late gene expression

Journal of Molecular Biology

Volumn 241, Issue 2, 1994, Pages 193-207

  Mann, Derek A ^a   Mikaélian, Ivan ^a   Zemmel, Rodney W ^a   Green, Sheila M ^a   Lowe, Anthony D ^a   Kimura, Tominori ^a   Singh, Mohinder ^a   Butler, P Jonathan G ^a   Gait, Michael J ^a   Karn, Jonathan ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

HIV; Rev; Rev response element; RNA binding proteins; RNA structure

Indexed keywords

RNA BINDING PROTEIN;

ARTICLE; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROTEIN RNA BINDING; RNA STRUCTURE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0028108364     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1994.1488     Document Type: Article

References (54)

1. Adachi, A., Gendelman, H. E., Koenig, S., Folks, T., Willey, R., Rabson, A. & Martin, M. A. (1986). Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol 59, 284-291.
2. Arrigo, S. J. & Chen, I. S. Y. (1991), Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr and env/vpu 2 RNAs. Genes Develop. 5, 808-819.
3. Arrigo, S. J., Wietsman, S., Zack, J. A. & Chen, I. S. Y. (1990). Characterization and expression of novel singly spliced RNA species of human immunodeficiency virus type 1. J. Virol 64, 4585-4588.
4. Arrigo, S. J., Heaphy, S. & Haines, J. K. (1992). In vivo binding of wild-type and mutant human immunodeficiency virus type 1 rev proteins: implications for function. J. Virol. 66, 5569-5575.
5. Bartel, D. P., Zapp, M. L., Green, M. R, & Szostak, J. W. (1991), HTV-1 rev regulation involves recognition of non-Watson-(Vick base pairs in viral RNA. Cell 67, 529-536.
6. Chang, D. A. & Sharp, P. A. (1989). Regulation by HIV rev depends upon recognition of splice site. Cell, 59, 789-795.
7. Cochrane, A. W., Chen, C.-H. & Rosen, C. A. (1990). Specific interaction of the human immunodeficiency virus rev protein with a structured region in the env m RNA. Proc. Nat. Acad. Sci., U.S.A. 87. 1198-1202.
8. Cook, K. S., Fisk, G. J., Hauber, J., Usman, N., Daly, T. J. & Rusche, J. R. (1991). Characterization of HTV-1 rev protein: binding and stoichiometry and minimal RNA substrate, Nucl. Acids Res. 19, 1577-1583.
9. D’Agostino, D. M., Felber, B. K., Harrison, J. E., & Pavlakis, G. N. (1992). The rev protein of human immunodeficiency virus type 1 promotes polysomal association and translation of gagjpol and vpujenv m RNAs. Mol Cell Biol 12, 1375-1386.
10. Daly, T. J., Cook, K. S., Gary, G. S., Maione, T. E. & Rusche, J. R. (1989). Specific binding of HTV-1 recombinant rev protein to the rev-responsive element in vitro. Nature (London), 342, 816-819.
11. Dayton, E. T., Powell, D. M. & Dayton, A. I. (1989). Functional analysis of CAR, the target sequence for the rev protein of HIV-1. Science, 246, 1625-1629.
12. Dayton, E. T., Konings, D. A. M., Powell, D. M., Shapiro, B. A., Butini, L., Maizel, J. V. & Dayton, A. I. (1992). Extensive sequence-specific information throughout the CAR/RRE, the target sequence of the human immunodeficiency virus type 1 rev protein. J. Virol. 66, 1139-1151.
13. Emerman, M., Vazeaux, R. & Peden, K. (1989). The rev gene product of the human immunodeficiency virus affects envelope specific RNA localization. Cell, 57, 1155-1165.
14. Feinberg, M. B., Jarrett, R. F., Aldovini, A., Gallo, R. C. & Wong-Staal, F. (1986). HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RXA. Cell, 46, 807-817.
15. Felber, B. K., Hadzopoulou-Cladaras, M., Cladaras, C. Copeland, T, & Pavlakis, G. X. (1989). Rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral m RNA. Proc. Nat. Acad. Sci., U.S.A. 86. 1495-1499.
16. Gorman, C. M., Padmanabliam, R. & Howard, B. H. (1983). High efficiency DNA-mediated transformation of primate cells. Science, 221, 551-553.
17. Guatelli, J. C., Gingeras, T. R. & Richman, D. D. (1990). Alternative splice acceptor utilization during human immunodeficiency virus type 1 infection of cultured cells. J. Virol. 64, 4093-4098.
18. Hadzopoulou-Cladaras, M., Felber, B. K., Cladaras, C., Athanassopoulos, A., Tse, A. & Pavlakis, G. N. (1989). The rev/art protein of human immunodeficiency virus type 1 affects viral m RXA and protein expression via a cis-acting sequence in the env region. J. Virol. 63, 1265-1274.
19. Hammarskjold, M.L., Heimer, J., Hammarskjold, B., Sangwan, I., Albert, L., & Rekosh, D. (1989). Regulation of human immunodeficiency virus env gene expression by the rev gene product. J. Virol. 63, 1959-1966.
20. Heaphy, S., Dingwall, C., Ernberg, I., Gait, M. J., Green, S. M., Karn, J., Lowe, A. D., Singh, M. & Skinner, M. A. (1990). HTV-1 regulator of virion expression (rev) protein binds to an RXA stem-loop structure located within the rev-response element region. Cell, 60. 685-693.
21. Heaphy, S., Finch, J. T., Gait, M. J., Karn, J. & Singh, M. (1991). Human immunodeficiency virus type 1 regulator of virion expression. rev, forms nucleoprotein filaments after binding to a purine-rich “bubble” located within the rev-responsive region of viral RNA. Proc. Nat. Acad. Sci., U.S.A. 88. 7366-7370.
22. Holland, S. M., Chavez, M., Gerstberger, S. & Venkatesan, S. (1992). A specific sequence with a bulged guanosine residue(s) in a stem-bulge-stem structure rev-responsive element RNA is required for trans-activation by human immunodeficiency virus type 1 rev, J. Virol. 66, 3699-3706.
23. Hope, T. J., Mc Donald, D., Huang, X., Low, J. & Parslow, T. G. (1990). Mutational analysis of the human immunodeficiency virus type 1 rev trans-activator: essential residues near the amino terminus. J. Virol. 64, 5360-5366.
24. Huang, X., Hope, T. J., Bond, B. L., Mc Donald, D., Grahl, K. & Parslow, T. G. (1991). Minimal rev-response element for type 1 human immunodeficiency virus. J. Virol. 65. 2131-2134.
25. Iwai, S., Pritchard, C., Mann, D. A., Karn, J. & Gait, M. J. (1992). Recognition of the high affinity binding site in rev-response element RXA by the human immunodeficiency virus type 1 rev protein. Nucl. Acids Res. 20, 6465-6472.
26. Jaeger, J. A., Turner, D. H. & Zuker, M. (1989a). Improved predictions of secondary structures for RNA. Proc. Nat. Acad. Sci., U.S.A, 86. 7706-7710.
27. Jaeger, J. A., Turner, D. H. & Zuker, M. (1989b). Predicting optimal and suboptimal secondary structures for RNA. Methods Enzymol. 183, 281-306.
28. Karn, J., Asseline, U., Churcher, M. J., Gait, M. J., Graeble, M. A., Green, S. M., Hamy, F., lwai, S., Kimura, T., Lamont, C., Lowe, A. D., Mann, D. A., Pritchard, C. & Singh, M. (1993). Transcriptional and post-transcriptional regulation of human immunodeficiency virus type-1 gene expression by the RXA-binding proteins tat and rev. In Focus on HIV, 1992 (Neu, H., Levy, J. A. & Weiss, R. A., eds), 98-129, Churchill Livingstone, London.
29. Karn, J., Churcher, M. J., Rittner, K., Kelley, A. C., Butler, P. J. G., Mann, D. A. & Gait, M. J. (1994). RNA binding assays for the regulatory proteins tat and rev. In HIV: A Practical Approach (Karn, J., ed.), Oxford University Press.
30. Kjems, J., Brown, M., Chang, D. D. & Sharp, P. A. (1991). Structural analysis of the interaction between the human immunodeficiency virus rev protein and the rev response element. Proc. Nat. Acad. Sci., U.S.A. 88, 683-687.
31. Kjems, J., Calnan, B. J., Frankel, A. D. & Sharp, P. A. (1992). Specific binding of a basic peptide from HIV-1 rev. FMBO J. 11. 1119-1129.
32. Laspia, M. F., Rice, A. P. & Matthews, M. B. (1990). Synergy between HTV-1 tat and adenovirus Ela is principally due to stabilization of transcriptional elongation. Genes Develop. 4, 2397-2408.
33. Lawrence, J. B., Cochrane, A. W., Johnson, C. V., Perkins, A. & Rosen, C. A. (1991). The HIV-1 rev protein: a model system for the coupled RXA transport and translation. New Biol. 3, 1220-1232.
34. Malim, M. H. & Cullen, B. R. (1991). HIV-1 structural gene expression requires the binding of multiple rev monomers to the viral RRE: implications for HTV-1 latency. Cell, 65. 241-248.
35. Malim, M. H. & Cullen, B. R. (1993). Rev and the fate of pre-m RNA in the nucleus: implications for the regulation of RXA processing in eukaryotes. Mol. Cell. Biol. 13, 6180-6189.
36. Malim, M. H., Hauber, J., Fenrich, R. & Cullen, B. R. (1988). Modulation of human immunodeficiency virus tat gene expression by the viral rev irons-activator. Nature (London), 335. 181-183.
37. Malim, M. H., Hauber, J., Le, S-Y., Maizel, J. V. & Cullen, B. R. (1989a). The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral m RNA, Nature (London), 338, 254-257.
38. Malim, M. H., Bohnlein, S., Hauber, J. & Cullen, B. R. (1989b). Functional dissection of the HIV-1 rev trans-activator: derivation of a irana-dominant repressor of rev function. Cell. 58, 205-214.
39. Malim, M. H., Tiloy, L. S., Mc Carn, D. F., Rusche, J. R., Hauber, J. & Cullen, B. R, (1990). HTV-1 structural gene expression requires binding of the rev trails-activator to its RXA target sequence. Cell, 60. 675-683.
40. Malim, M. H., Mc Carn, D. F., Tiley, L. S. & Cullen, B. R. (1991). Mutational definition of the human immunodeficiency virus type 1 rev activation domain. J. Virol. 65, 4248-4254.
41. Messing, J. (1983), New M13 vectors for cloning. Methods Enzymol. 101, 20-78.
42. Olsen, H. S., Nelbrock, P., Cochrane, A. W. & Rosen, C. A. (1990). Secondary structure is the major determinant for interaction of HTV rev protein with RNA. Science, 247, 845-848.
43. Rosen, C. A., Terwilliger, E., Dayton, A. I., Sodrowski, J. G. & Haseltine, W. A. (1988). Intragenic cis-acting art-responsive sequences of the human immunodeficiency virus. Proc. Nat. Acad. Sci., U.S.A. 85, 2071-2075.
44. Schwartz, S., Felber, B. K., Benko, D. M., Fenyo, EM. & Pavlakis, G. N. (1990), Cloning and functional analysis of multiply spliced m RNA species of human immunodeficiency virus type I. J. Virol. 64, 2519-2529.
45. Schwartz, S., Campbell, M., Nasikoulas, G., Harrison. J., Felber, B. R. & Pavlakis, G. N. (1992a). Mutational inactivation of an inhibitory secpience in human immunodeficiency virus type 1 results in rev-independent gag expression. J. Virol. 66, 7176-7182.
46. Schwartz, S., Felber, B. K. & Pavlakis, G. N. (1992b). Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of rev protein. J. Virol. 66, 150-159.
47. Smith, J. M. & Thomas, D. J. (1990). Quantitative analysis of one-dimensional gel electrophoresis profiles. CA BIOS, 6, 93-99.
48. Kodroski, J., Goh, W. C., Rosen, C. A., Dayton, A., Terwilliger, E, & Haseltine, W. A. (1986). A second post-transcriptional activator gene required for HTLV-III replication. Nature (London), 321. 412-417.
49. Tiley, L. S., Malim, M. H., Tewary, H. K., Rtoekley, P. G. & Cullen, B. R. (1992). Identification of a high-affinity RXA-binding site for the human immunodeficiency virus type 1 rev protein. P roc. Nat. Arad. Sci., U.S.A. 89, 758-762.
50. Tyagarajan, K., Monforte, J. A, & Hearst, J. E. (1991). RXA folding during transcription by T7 RNA polymerase analyzed using the self-cleaving transcript assay. Biochemistry, 30, 10920-10924.
51. Wingfield, P. T., Stahl, S. J., Payton, M. A., Venkatesan, S., Misra, M. & Steven, A. J. (1991). HIV-1 rev expressed in recombinant Escherichia coli: purification, polymerization and conformational properties. Biochemistry, 30, 7527-7534.
52. Zapp, M. L. & Green, M. R. (1989). Sequence-specific binding by the HIV-l rev protein. Nature (London), 342, 714-716.
53. Zapp, M. L., Hope, T. J., Parslow, T. G. & Green, M. R. (1991). Oligomerization and RXA binding domains of the type 1 human immunodeficiency virus rev protein: a dual function for an arginine-rich binding motif. Proc. Nat. Acad. Sci., U.S.A. 88, 7734-7738.
54. Zuker, M. (1989). On finding all suboptimal foldings of an RNA molecule. Science, 244, 48-52.